TransDigm Group CapEx increased by 18.3% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.8%, from $56.00M to $71.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 20.6% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.00M | $25.00M | $25.00M | $32.00M | $29.00M | $33.00M | $31.00M | $35.00M | $36.00M | $37.00M | $36.00M | $48.00M | $40.00M | $41.00M | $42.00M | $56.00M | $58.00M | $66.00M | $60.00M | $71.00M |
| QoQ Change | — | +25.0% | +0.0% | +28.0% | -9.4% | +13.8% | -6.1% | +12.9% | +2.9% | +2.8% | -2.7% | +33.3% | -16.7% | +2.5% | +2.4% | +33.3% | +3.6% | +13.8% | -9.1% | +18.3% |
| YoY Change | — | — | — | — | +45.0% | +32.0% | +24.0% | +9.4% | +24.1% | +12.1% | +16.1% | +37.1% | +11.1% | +10.8% | +16.7% | +16.7% | +45.0% | +61.0% | +42.9% | +26.8% |
| Segment | FY'21 | FY'22 |
|---|---|---|
| Power And Control | $65.00M | $63.00M |
| Airframe | $37.00M | $52.00M |
| Non Aviation Related Business | $2.00M | $3.00M |
| Total | $105.00M | $119.00M |
All segment values are derived from annual filings.
Airframe, Non Aviation Related Business, Power And Control were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.